TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Clearance of beta-2 microglobulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clearance of phosphate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum concentration of C3a, C5a, myeloperoxidase and PF-4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained deep remission rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: safety in pregnant mothers
Endpoint domain: Adverse events/effects
Primary endpoint: safety in newborns
Endpoint domain: Adverse events/effects
Primary endpoint: outcome of pregnancy
Endpoint domain: Physiological/clinical
Primary endpoint: Induction/Augmentation delivery intervals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Capsular Apposition to Intraocular Lens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: relapse profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Improvement in blood pressure parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in vascular endothelial function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in levels of β1 subunit expression of Maxi-K + channel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 28-day all course mortality
Endpoint domain: Mortality/survival
Primary endpoint: Progression Free Survival (PFS) at 7 Months
Endpoint domain: Mortality/survival
Primary endpoint: Change From Baseline in Walking Speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in Current Opioid Misuse Measure (COMM) Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Composite adherence metric
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nightmare Frequency Past Week
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: SB-specific HRQOL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Cervical Range of Motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mixed Chimerism
Endpoint domain: Physiological/clinical
Primary endpoint: Feasibility of producing an infusion ready CD4+ T-cell-depleted hematopoietic product
Endpoint domain: Resource use
Primary endpoint: Sleep pattern measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total weight of milk expressed during the first 10 days post-partum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time taken to express a fixed volume of milk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time taken for first milk to appear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feeding intolerance at day-3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Citrulline generation test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Biphasic Ethanol Effects Scale (BAES)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive function test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: maximum international normalised ratio (INRmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported adherence to study cigarettes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self Reported Dependence Using the Nicotine Dependence Syndrome Scale (NDSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: saccharin transit time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percentage of Participants With Mean Hb Value ≥10 g/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean Hb Change From Baseline to Average Hb From Weeks 16-24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Disease exacerbation in CD patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease exacerbation in UC patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease exacerbation in UC-Pouch patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dignity Impact Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Molecular Response (MR)^4.5 rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of PEG tube placement
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: safety of cataract surgery
Endpoint domain: Adverse events/effects
Primary endpoint: efficacy of cataract surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of program core components
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: set insertion failures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sleep quality of one night before surgery
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: sleep quality of first night after surgery
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: sleep quality of third night after surgery
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Time to Recurrence of Brain Tumor
Endpoint domain: Mortality/survival
Primary endpoint: optimal stimulation of nutritional intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: effect of ghrelin on muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ongoing implantation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change in Cancer Behavior Inventory (CBI) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 7 days survival
Endpoint domain: Mortality/survival
Primary endpoint: Best radiographic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of treatment-related grade 3 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Parental Sense of Competence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in subsynovial connective tissue thickness after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Frequency of deep venous thrombosis (DVT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Growth rate of square-root transformed area of EZ band loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantity of Milk Produced
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in ventricular rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Multiple Sclerosis Walking Scale-12 (MSWS-12)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in daily fruit and vegetable servings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cholecystokinin (CCK) release
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Mean right ventricular end-diastolic volume indexed to body surface area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of deceased patients (all-cause mortality)
Endpoint domain: Mortality/survival
Primary endpoint: Response Rate (Progression)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Puff topography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite outcome of ACS/unstable angina, Stroke, MI, and Mortality
Endpoint domain: Mortality/survival
Primary endpoint: Change in tibial stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum concentrations of oxidative stress markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the Timed up And Go Test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient's adhesion to the digital compilation
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Mammographic percent density (MPD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of Amyloid protein in the brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Level of shame propensity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of SA compared to the clinical data obtained in baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in SKAMP Combined Scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prevalence of microbial contamination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Reduced all cause, cardiovascular, and heart failure hospitalizations
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Efficacy Failure
Endpoint domain: Mortality/survival
Primary endpoint: Biopsy-proven Acute Rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: safety and efficacy of E7 TCR cells plus aldesleukin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breast maturation scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Height velocity (HV) during the first 26 weeks of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of adverse events, including injection site reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Number and Percentage of Participants with Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: number of Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical benefit rate by cohort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Overall Disease Severity (ODS) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rate of brain metastases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Overall Response Rate in the CNS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Healthy oral tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With ICU-attributable Staphylococcus Aureus Clinical Cultures
Endpoint domain: Adverse events/effects
Primary endpoint: Gestational age estimation accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of treatment regimen
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Fatigue Level
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Incidence of Flushing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Flushing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Flushing Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Patients With a Live Birth
Endpoint domain: Mortality/survival
Primary endpoint: Level of information on tobacco-related risks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Access to smoking cessation aids
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Adequacy of Suppression of Estradiol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Liver function results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Coagulation results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change at Unified Parkinson's disease rating scale III over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of Treatment-Emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Total use of midazolam and remifentanil drug consumptions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction of patient and surgeon
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adverse events during operation and in the recovery room
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of infant sleep problem
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Working memory function
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Invasive arterial blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Injection drug use
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in liver steatosis at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline in liver fibrosis at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of primary adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Contouring variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remifentanil consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change of BFI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of Cold Air Stimulus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in postoperative shivering
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: technical success rate of filter placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Decrease of the pressure pain thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: 1-Year Change in Immediate Recall/Learning/Episodic Memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: 24-hour pharmacokinetic profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Local tolerability including local infusion site tolerability
Endpoint domain: Adverse events/effects
Primary endpoint: Total score of Melbourne Assessment of Unilateral Upper Limb Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: difference AMH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: difference AFC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: difference E2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: difference FSH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Acute and Late Genitourinary Toxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Acute and Late Lower Gastrointestinal Toxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Maximum IAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leiden-Surgical Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in excess arm volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained smoking abstinence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Abnormalities in clinical laboratory tests
Endpoint domain: Adverse events/effects
Primary endpoint: LVEF changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in tumour Ki-67
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Rate of Target Lesion Failure (TLF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Histological pattern of collagen fibers organization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence of reflux
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percentage of subjects with an established microbiological diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of Pregnancies with GDM diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Number of Newborns with Large for Gestational Age (LGA) Birthweight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Number of pregnant women with Gestational Hypertension & Pre-Eclampsia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Birth within 24 hours of induction
Endpoint domain: Mortality/survival
Primary endpoint: Relative change in frequency of moderate to severe hot flushes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total clearance of Wuchereria bancrofti microfilaria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Pain management index (PMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PGE2 levels in colon mucosa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: regulation of cerebral blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Tumour standardised uptake values (SUV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Positive and negative predictive value of sestamibi scanning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Jebsen-Taylor Hand Function Test (JTHFT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bruininks-Oseretsky Test of Motor Proficiency (2nd ed.) (BOTMP-II)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to disease progression in bone metastasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in 6-Minute Walk Test (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Borg dyspnea index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in modified NYHA functional class
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: probing pocket depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: Number of Patients With Chronic Post-amputation Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of chemotherapy related grade 3 or higher adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Long-acting reversible contraception use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change of Delta Pulse Pressure Value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change of Delta Down Value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Etanercept concentration-time courses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in random blood sugar
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in self-reported medication adherence behaviors
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in glucose, insulin, and IGF levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Methacholine PC20
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of epidural medication boluses required
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Memory retrieval/word finding assessment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Induction of sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of vericiguat's metabolite M-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of vericiguat's metabolite M-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unified Wilson's Disease Rating Scale (UWDRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numeric Rating Scales (NRS)
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Activity of Daily Living Scale (ADL)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage of Participants Who Achieved Clinical Remission as Measured by Partial Mayo Score (PMS) at Week 8
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes